Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ TAT-cyclo-CLLFVY

Click to view available options
Quantity:
1 mg
Description
TAT-cyclo-CLLFVY is a selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50 = 1.3 μM) . Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. Also reduces tubularization of hypoxic HUVECs.
Specifications
Specifications
Purity | 95% |
CAS | 1446322-66-2 |
Content And Storage | Store at -20°C |
Description | HIF Inhibitors |
Molecular Weight (g/mol) | Observed M.W.: 2559.1 |
Quantity | 1 mg |
Structural Form | C111H188N42O24S2 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction